At 8:30AM, the early indicator SGX Nifty was down 10 points at 8,675.
Technical analysts suggest that since the Nifty has managed to surpass the resistance the of 8,550 levels which is a bullish signal.
Also Read
Global Markets
Asian markets opened higher after discouraging US jobs data signalled that the US Fed may not cut interest rates soon. However, profit taking at higher levels pared all the early gains with most markets in the region closed for trading today. Japanese shares were trading with marginal losses down 0.2% while Straits Times was trading flat with negative bias. Stock markets in Hong Kong and China are closed today
US markets snapped two day losing streak to end higher on Thursday ahead of the March jobs data due for release on Friday. The Dow Jones industrial average rose 65 points to 17,763, the S&P 500 gained 7 points to close at 2,066.96 and the Nasdaq Composite ended 7 points higher at 4,886.94. Further, the Labour Department on Friday said that 126,000
Stocks to watch
Among the rate sensitive shares, bank shares will be in focus ahead of the RBI policy meet tomorrow.
Wipro may see some action after the IT major inducted four new members into its group executive council. The new members include Abid Ali Neemuchwala, the newly-appointed group president and chief operating officer (COO); and Anand Padmanabhan, chief executive and president of the energy & utilities business unit.
Nalco may gain after the company achieved highest ever gross turnover of Rs 7,774 crore (provisional) against Rs 7,024 crore recorded in 2013-14, an increase of more than 10%.
NTPC may be in focus amid reports that the country's largest power producer will more than double its current installed capacity to 90,000 MW in the next ten years.
Bharat Electronics will be in focus after the state-owned company reported provisional figures for fiscal 2014-15 with 8% growth in turnover at Rs 6,671 crore.
SBI will be in action after the state-owned bank allotted 10.04 crore shares on preferential basis to Government of India at Rs 295.59 per equity share.
Aurobindo Pharma is likely to edge higher after the company today said it has received USFDA approval for Sildenafil injection used for treating adult patients (18 and above years) with pulmonary arterial hypertension.
AstraZeneca Pharma India may firm up after the company entered into an agreement with AstraZeneca UK Ltd for reimbursement of certain costs incurred for marketing and promotion of new product launches.
Bosch may see some pressure after the company declared a lockout after a go-slow strike by Labour Union and workmen of Jaipur plant.
Adlabs Entertainment will make its debut on the bourses today. The offer price was revised lower to Rs 180-215 from Rs 221-230 earlier because of poor response from institutional investors. Bharat
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)